Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus
暂无分享,去创建一个
P. Brown | C. Barry | D. Dittmer | D. Ganem | R. Renne | N. Compitello
[1] A. Rickinson. Epstein-Barr virus. , 2001, Virus research.
[2] G. Nabel,et al. p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.
[3] T. Schulz,et al. Latent Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with RING3, a Homolog of theDrosophila Female Sterile Homeotic (fsh) Gene , 1999, Journal of Virology.
[4] E. Robertson,et al. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.
[5] C. Rabkin,et al. Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. , 1999, The Journal of infectious diseases.
[6] P. A. Peterson,et al. DNA Microarrays of the Complex Human Cytomegalovirus Genome: Profiling Kinetic Class with Drug Sensitivity of Viral Gene Expression , 1999, Journal of Virology.
[7] F. Christians,et al. Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1 , 1999, Cell.
[8] C. Boshoff,et al. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. , 1999, Virology.
[9] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[10] E. van Marck,et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[12] A. Haase,et al. A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.
[13] D. Ganem,et al. Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells , 1998, Journal of Virology.
[14] G. Kochs,et al. Mx proteins: mediators of innate resistance to RNA viruses. , 1998, Revue scientifique et technique.
[15] D. Ganem,et al. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. , 1997, The Journal of clinical investigation.
[16] C. Boshoff,et al. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. , 1997, Journal of human virology.
[17] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[18] D. Ganem. KSHV and Kaposi's Sarcoma: The End of the Beginning? , 1997, Cell.
[19] L. Rainbow,et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.
[20] Yubin Du,et al. Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins , 1997, Oncogene.
[21] G. Nabel,et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. , 1997, The New England journal of medicine.
[22] S. Speck,et al. Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp) , 1997, Journal of virology.
[23] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[25] W. Zhong,et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.
[26] N. Raab-Traub. Pathogenesis of Epstein–Barr virus and its associated malignancies , 1996 .
[27] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[28] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[29] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[31] N. Mechti,et al. Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*) , 1995, The Journal of Biological Chemistry.
[32] D. Baltimore,et al. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] B. Sugden,et al. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene , 1995, Journal of virology.
[34] T. Shenk,et al. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Alwine,et al. Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex , 1994, Journal of virology.
[36] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[37] Carlos Lopez,et al. Human Herpesviruses: List of contributors , 2007 .
[38] K. Jones,et al. Tat and the HIV-1 promoter: A model for RNA-mediated regulation of transcription , 1993 .
[39] P. Pitha,et al. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon. , 1992, Virology.
[40] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[41] G. Hayward,et al. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1 , 1991, Journal of virology.
[42] B. Sugden,et al. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection , 1989, Journal of virology.
[43] M. Baluda,et al. Loss of viral receptors in homologous interference by ultraviolet-irradiated Newcastle disease virus. , 1959, Virology.
[44] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[45] D. Botstein,et al. Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.
[46] P. Brown,et al. DNA arrays for analysis of gene expression. , 1999, Methods in enzymology.
[47] B. Williams,et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[48] K. Struhl,et al. Yeast transcriptional regulatory mechanisms. , 1995, Annual review of genetics.
[49] P. Luciw,et al. Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3). , 1993, Virology.
[50] M. Ptashne. A Genetic Switch , 1986 .
[51] T. Shenk,et al. Relief of p 53-mediated transcriptional repression by the adenovirus E 1 B 19-kDa protein or the cellular Bcl-2 protein ( apoptosis / transcriptional regulation ) , 2022 .